title: The hexosamine biosynthesis pathway regulates insulin secretion via protein glycosylation in mouse islets.
abstract: The hexosamine biosynthesis pathway plays a role in the modification of cellular proteins via the provision of substrate for addition of O-linked N-acetylglucosamine (GlcNAc). The relative importance of the GlcNAc modification of proteins to insulin secretion from pancreatic beta-cells has not been investigated and so remains unclear. In the present study, we show that inhibition of the hexosamine biosynthesis pathway decreases insulin secretion from mouse islets in response to a number of secretagogues, including glucose. This impairment in beta-cell function could not be attributed to reduced islet insulin content, altered ATP levels, or cell death and was restored with the addition of N-acetylglucosamine, a substrate that enters the pathway below the point of inhibition. Western blot analysis revealed that decreased islet protein glycosylation paralleled the decrease in insulin secretion following inhibition of the pathway. In conclusion, the data suggest a role for the hexosamine biosynthesis pathway in regulating the secretion of insulin by altering protein glycosylation. This finding may have implications for the development of type 2 diabetes, as chronic increase in flux through the hexosamine biosynthesis pathway may lead to the deterioration of beta-cell function via abnormal protein glycosylation.
authors.affiliation: Department of Medicine, Royal Melbourne Hospital, University of Melbourne, Parkville, Vic. 3050, Australia.
authors.forename: Sakeneh
authors.initials: S
authors.lastname: Zraika
authors.forename: Marjorie
authors.initials: M
authors.lastname: Dunlop
authors.forename: Joseph
authors.initials: J
authors.lastname: Proietto
authors.forename: Sofianos
authors.initials: S
authors.lastname: Andrikopoulos
mesh_terms: D000117:Acetylglucosamine / Q000378:metabolism / Q000494:pharmacology; D000255:Adenosine Triphosphate / Q000378:metabolism; D000818:Animals; D000878:Anthranilate Synthase; D001377:Azaserine / Q000494:pharmacology; D002470:Cell Survival / Q000187:drug effects; D002478:Cells, Cultured; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005947:Glucose / Q000378:metabolism / Q000494:pharmacology; D006031:Glycosylation; D006595:Hexosamines / Q000096:biosynthesis*; D007328:Insulin / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D019884:Nitrogenous Group Transferases / Q000037:antagonists & inhibitors / Q000378:metabolism; D011506:Proteins / Q000378:metabolism*
chemical_list: D004791:Enzyme Inhibitors; D006595:Hexosamines; D007328:Insulin; D011506:Proteins; D001377:Azaserine; D000255:Adenosine Triphosphate; D019884:Nitrogenous Group Transferases; D000878:Anthranilate Synthase; C020655:anthranilate synthase, glutamine amidotransferase subunit; D005947:Glucose; D000117:Acetylglucosamine